Fascioliasis is a zoonotic disease caused by
Fasciola hepatica and
F. gigantica trematode liver fluke. It is estimated that 17 million people are infected with these parasites, with an additional 91.1 million at risk for this infection (
1). In Eastern Europe, South America, and North Africa,
F. hepatica is particularly endemic. Turkish studies have reported a prevalence of 0.03% - 0.8% for
F. hepatica infection (
2). Children are generally more commonly infected than adults, although infections appear to be more serious in women with higher liver or biliary complications (
3). Sheep, goat, cattle and other ruminants are mainly contaminated with trematoda. Transmission to people who are unintended final hosts takes place after the ingestion of contaminated aquatic vegetation such as watercress or metacercariae (
4,
5). Oviposition occurs within 3 - 4 months after the initial infection, and adult flukes have a life span of up to 10 years. Clinical presentations typically occur after the parasite remains in the liver (
6). While two clinical phases of fascioliasis have been recognized in humans, diagnosis and distinguishing between them is often difficult. The acute phase includes larval migration to the liver and lasts 1 - 3 months after metacercariae ingestion. The chronic phase begins when the adult flukes enter the bile ducts, which can last many years. Nearly half of patients during the chronic period may be asymptomatic (
7). Many studies have reported cases of mixed-phase fascioliasis in recent years (
8-
11). Although fasciolosis is generally considered as a notable veterinary problem, human fasciolosis has recently been regarded as the main health issue in numerous countries (
12,
13). According to the World Health Organization (WHO) report, Iran has been placed among the six countries recognized to have a serious concern with fasciolosis (
2,
14,
15). Fasciolosis has led to two important epidemics in Iran in 2009 and 2011, respectively, which have been the biggest epidemics of fasciolosis in history (
16,
17). According to the seroprevalence studies of fasciolosis in Yasouj (2011), Lorestan (2015) and Isfahan (2014), in Iran, anti-
Fasciola antibodies were positive in 1.8, 0.7 and 1.7% of the cases, respectively (
9,
10,
18).
Several techniques, including serological and parasitological methods are used for the diagnosis of fasciolosis. Parasitological methods have the highest specificity, but some factors such as low rate of parasite eggs, transient infection, and acute and obstructive infections reduce the sensitivity of these methods. Serological tests are usually used for the recognition of anti-
Fasciola antibodies in serum samples in the acute phase and ectopic fasciolosis. These methods are appropriate for diagnosing chronic fasciolosis by identifying specific antigens in stool samples and antibodies in the serum as well (
19). Therefore, serological methods such as ELISA are commonly used to diagnose human fasciolosis in Iran (
20).